Why BMI keeps failing the people who train hardest

Picture the scenario: you train four or five times a week, your weight hasn't shifted in years, and your GP's annual check ticks every box. BMI — normal. Yet somewhere beneath that reassuring number, LDL cholesterol is creeping upward and apolipoprotein B is signalling arterial risk your blood-pressure cuff will never detect. The metric designed to tell you everything is, in fact, telling you almost nothing.

BMI was formulated in the 19th century as a population-level epidemiological tool — a simple ratio of weight in kilograms divided by height in metres squared. As Professor Paul Lee states plainly in Practical Regeneration (2026), it is 'a blunt tool… designed to track population health, not to assess individual fitness', one that cannot distinguish muscle from fat, ignores bone density, and takes no account of ethnic differences in body composition. The problem is not that BMI is useless in aggregate; it is that it was never designed to tell one person, at one moment in time, whether their internal biology is thriving.

The evidence for this limitation has grown sharper. A 2026 peer-reviewed review concluded that relying on BMI to assess cardiometabolic risk overlooks crucial phenotypic heterogeneity, and recommended inflammatory biomarkers, DEXA- or MRI-measured visceral adiposity, and cardiorespiratory fitness as superior alternatives. More vividly, a 2025 study of 111 physically active children found only moderate agreement (κ=0.532) between BMI-based classification and a metabolic biomarker framework: 20 individuals labelled merely 'overweight' were reclassified as carrying preclinical obesity with elevated LDL and apolipoprotein B, while four labelled 'obese' were reclassified as non-obese once elevated lean mass was accounted for. Active bodies get misclassified in both directions.

For the 40–70-year-old who trains, optimises and supplements, this misclassification risk is arguably highest of all. Muscle mass pushes BMI upward; visceral fat hides behind a 'normal' reading. The scale rewards neither discipline nor biology. So if not BMI, then what — and where does the real picture actually live?

What a full blood panel actually looks at

The real picture lives in the blood — but only if you're testing the right things.

Standard NHS screening was designed with a specific job in mind: detecting disease that has already developed. That is a different task from spotting the slow biological drift that precedes it, which is why many of the markers most relevant to optimisation never appear on a routine form. The Regen Blood Panel was built around a different question entirely: not 'are you ill?' but 'how well are your repair systems actually running?'

The panel covers 32 biomarkers across six biological systems, each probing a distinct dimension of function:

• Inflammation — including hs-CRP, which maps low-grade chronic inflammation that quietly accelerates biological ageing and tissue degradation long before it registers as a diagnosable condition.
• Metabolic — including HOMA-IR, a measure of insulin sensitivity that can reveal early resistance while fasting glucose still reads as normal, opening a critical window for intervention.
• Hormonal — tracking the trajectory of key hormones along the hypothalamic-pituitary-gonadal axis, changes that no anthropometric measure can detect.
• Cellular energy — assessing how efficiently the body's cells are generating and using energy at a mitochondrial level.
• Cardiovascular — including ApoB and Lp(a), both stronger predictors of arterial event risk than total cholesterol or LDL alone, and both routinely absent from standard screening.
• Liver and renal — monitoring the clearance and metabolic infrastructure that underpins every other system.

Blood is drawn at Harley Street by a trained clinician, results are physician-reviewed, and a personalised regeneration pathway is ready within five days. This is what Professor Paul Lee's Chemistry pillar looks like in practice: not a broad disease screen, but a targeted read of the internal environment that governs how well the body regenerates.

The hormone picture hiding behind a normal weight

Testosterone levels tell a story that weight cannot. Among 1,222 symptomatic men aged 40–70, a cross-sectional study found testosterone deficiency in 55% of the cohort — more than half. What makes the figure striking is what sits alongside it: 97.2% of deficient men carried at least one co-morbidity, and their median testosterone (2.55 ng/mL) was roughly half that of healthy peers (4.7 ng/mL, p<0.001, adjusted for age). That is not a marginal shortfall. It is a biological state that looks, from the outside, indistinguishable from a man carrying a normal BMI and getting on with his week.

The harder problem is that subjective sense of wellbeing is an unreliable guide. A systematic review of 40 studies found that clinical signs and symptoms alone show weak correlation with testosterone levels — the likelihood ratios are too low for clinical use. Fatigue, slower recovery, reduced drive: each can have a half-dozen explanations. Only a blood panel resolves the ambiguity. The Chemistry pillar of the Regeneration by Design framework is built on exactly this premise — the internal environment must be measured, not guessed at.

The same logic applies across sex: perimenopause drives its own cascade of oestrogen, progesterone, and DHEA shifts that no scale or symptom inventory reliably tracks, and women in the same 40–70 age band face parallel blind spots. Women's perimenopause trajectories deserve their own dedicated treatment beyond the scope of this piece.

Crucially, the panel is not a one-off verdict. Research demonstrates that HIIT raised total testosterone by approximately 17% in lifelong sedentary men aged around 62 — meaning the numbers respond measurably to what you do. Monitor once and you have a snapshot; monitor quarterly and you have a feedback system that can tell you whether your programme is actually working at a hormonal level.

The above covers general wellness monitoring only and does not constitute medical advice. Consult a qualified healthcare professional for any clinical concerns.

Reading biomarkers as a system, not a scorecard

Numbers without context are noise. The real value of a panel lies not in any single marker but in the relationships between them — and what those relationships reveal about the biological environment your cells are working in.

Professor Paul Lee's argument in Practical Regeneration is fundamentally epigenetic: most meaningful change comes not from interrogating your genetic code but from improving the environment that code responds to. A panel is a read of that environment. It shows not what you inherited, but what your body is currently doing with it.

That distinction matters because the systems being measured are not independent. Chronic low-grade inflammation suppresses testosterone production; depressed cellular energy undermines sleep architecture and slows tissue repair; disrupted insulin sensitivity amplifies inflammatory signalling — each variable pulling at the others. An isolated elevated reading can be transient noise; a pattern across systems is a signal, and it points to an environment problem rather than a fixed biological verdict.

This is the Chemistry pillar of the Regeneration by Design framework made concrete. The internal chemical environment is not passively inherited — it is actively shaped by how you train, recover, eat, sleep, and manage cumulative load. Poor results are not a sentence. They are a description of current conditions, and conditions can be changed.

A panel, read this way, is less a scorecard than a map: here is where your environment stands today. Maps exist to be used.

The personal MOT: a quarterly practice, not a one-off event

Monitoring is most useful when it runs on a rhythm. Practical Regeneration frames the personal MOT as a monthly standing practice — movement checks, posture, single-leg stability — not an annual event triggered by something going wrong. The blood panel extends that logic into the biochemical layer: test quarterly, and each result gains meaning from the one before it.

This is the premise of the Digital Body Bank: capture a baseline while the body is functioning well, and every subsequent panel builds a longitudinal record. A single reading is a coordinate; four readings across a year are a trajectory. Is hs-CRP edging down since sleep was prioritised? Has HOMA-IR shifted since dietary timing changed? The HIIT/testosterone data makes the feedback principle concrete — a ~17% rise in total testosterone across a training cycle is visible in the bloodwork, not merely felt.

The Regen Scan adds a functional layer alongside the biochemical one. MAI Motion's markerless 3D capture tracks 15 skeletal keypoints at 120 frames per second to produce a Motion Age score — a read of how the body actually moves. Biochemical age and movement quality measured together give a two-layer internal picture that neither scale nor mirror can approach.

As the panel tracks the body's internal environment, so daily recovery shapes it. The Regen PhD Pod — coordinating heat, therapeutic light, vibration, magnetic fields, and targeted scents — operates as a wellness recovery tool designed to support the repair conditions that quarterly monitoring is built to track.

Four panels across twelve months create a dataset in which trends in ApoB, testosterone, and hs-CRP become legible — clear enough to confirm what is working, and specific enough to direct what to change next.

What to do next with your numbers

The first step is the simplest: find out where you actually stand. If your last NHS check did not include ApoB, Lp(a), HOMA-IR, or a hormonal profile, you do not yet have a complete picture — and those gaps are precisely where modern cardiometabolic and hormonal risk tends to hide.

Once results are in hand, treat them as a starting coordinate rather than a verdict. The epigenetic logic Professor Paul Lee sets out in Practical Regeneration holds here: the biological environment that produced those numbers is not fixed. Resistance training shifts insulin sensitivity and HOMA-IR within weeks of consistent effort. Prioritising sleep quality — seven to nine hours with reduced evening light exposure — measurably lowers hs-CRP over time. Reducing processed fats and refined carbohydrates targets both inflammatory and metabolic markers simultaneously. These are not abstractions; they are the specific levers that the Chemistry pillar of Regeneration by Design is designed to pull, and the panel tells you which ones need pulling most urgently.

Before acting on anything clinical, share your results with a qualified healthcare professional — numbers in isolation need expert interpretation, and what follows here is a starting map, not a clinical plan.

For readers who want a structured next step, Regen PhD's physician-reviewed pathway translates panel findings into a targeted programme built around your individual results. Knowing your internal environment is not a passive observation. It is how designing it begins.

1. [1] Prevalence of testosterone deficiency among aging men with and without morbidities. (2019). https://doi.org/10.1080/13685538.2019.1621832 https://doi.org/10.1080/13685538.2019.1621832
2. [2] Predicting low testosterone in aging men: a systematic review. (2016). https://doi.org/10.1503/cmaj.150262 https://doi.org/10.1503/cmaj.150262